Nasal Cannula Market size is expected to grow significantly from 2020 to 2026. Nasal cannula is a tube, split in two prongs that are placed in a patient’s nostrils to deliver supplemental oxygen. The oxygen is delivered in a variable way, depending on the patient’s breathing rate. These devices see applications in diseases such as pneumonia and chronic obstructive pulmonary disease (COPD).
Get more details on this report - Request Free Sample PDF
Increasing incidence of breathing disorders such as COPD and asthma will primarily drive the demand for nasal cannulas over the forecast period. Increasing rate of smoking will contribute to the growing incidence of COPD. According to the Center for Disease Control (CDC), about 15 million adults in the U.S. suffered from COPD in 2011. This number is expected to rise, boosting the market demand for nasal cannulas.
The low cost of nasal cannulas will be another factor driving the market expansion over the forecast period. Nasal cannulas retail at 5-10 USD in the U.S. This low cost of nasal cannulas will spur the adoption rates. Additionally, a growing preference towards home healthcare in the developed economies will increase the product demand. These factors will fuel the market expansion over the forecast period.
However, uncertain regulatory scenario might restrict the market growth during the forecast period. Furthermore, low rate of technology adoption in the developing economies could impede the market expansion in the short run.
By type, the nasal cannula market demand is segmented into curved prong cannula, flared prong cannula, curved and flared prong cannula and straight prong cannula. The curved and flared prong cannula segment is expected to hold a significant market share in the future. This type of cannula combines the benefits of curved and flared prong cannulas and is one of the most used type of cannula. These factors will augment segment expansion over the forecast period.
Based on material, the market is categorized into plastic and silicone. The silicone segment will exhibit lucrative growth over the forecast period. The high growth can be attributed to the durable and environment friendly nature of silicone. These factors will fuel the segment growth over the analysis time frame.
Nasal cannulas are used in hospitals, ambulatory care centers, home care settings and long-term care centers. The home care settings segment will exhibit robust growth over the forecast period. The growth can be attributed to increasing preference for home care among patients. Furthermore, increased patient compliance due to easy access of care will boost the segment growth.
North America nasal cannula market revenue will account for substantial market share over the forecast period. The growing burden of respiratory diseases coupled with increasing surgeries will fuel the market expansion over the forecast period. Furthermore, low cost of nasal cannulas and growing awareness regarding the benefits of oxygen therapy will drive the market expansion over the forecast period.
Some of the prominent players operating in the nasal cannula market share are Flexicare Medical, Medin Medical innovations, Fisher and Paykel Healthcare Ltd., Salter Labs, Medtronic PLC, Sorin Group, Terumo Corporation, Smiths Medical, Teleflex and Vapotherm. These players adopt various strategies such as new product launch, mergers and acquisitions and geographical expansion to capture larger market share.
Nasal Cannula Market, By Type, 2015-2026 (USD Million)
Nasal Cannula Market, By Material, 2015-2026 (USD Million)
Nasal Cannula Market, By End-use, 2015-2026 (USD Million)
The above information is provided for the following regions and countries: